Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2011 (2011), Article ID 832163, 5 pages
http://dx.doi.org/10.4061/2011/832163
Research Article

Leptin: A Correlated Peptide to Papillary Thyroid Carcinoma?

1Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, 1985717413 Tehran, Iran
2Department of Biology, Faculty of Basic Sciences, Science Research Campus of Islamic Azad University, 1939614484 Tehran, Iran

Received 25 April 2011; Revised 11 July 2011; Accepted 12 August 2011

Academic Editor: Oliver Gimm

Copyright © 2011 Mehdi Hedayati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Liu, X. J. Liu, G. Barry, N. Ling, R. A. Maki, and E. B. De Souza, “Expression and characterization of a putative high affinity human soluble leptin receptor,” Endocrinology, vol. 138, no. 8, pp. 3548–3554, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Wauters, R. V. Considine, and L. F. Van Gaal, “Human leptin: from an adipocyte hormone to an endocrine mediator,” European Journal of Endocrinology, vol. 143, no. 3, pp. 293–311, 2000. View at Google Scholar · View at Scopus
  3. M. W. Schwartz, R. J. Seeley, L. A. Campfield, P. Burn, and D. G. Baskin, “Identification of targets of leptin action in rat hypothalamus,” Journal of Clinical Investigation, vol. 98, no. 5, pp. 1101–1106, 1996. View at Google Scholar · View at Scopus
  4. R. S. Ahlma, D. Prabakaran, C. Mantzoros et al., “Role of leptin in the neuroendocrine response to fasting,” Nature, vol. 382, no. 6588, pp. 250–252, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. H. F. Escobar-Morreale, F. E. Del Rey, and G. M. De Escobar, “Thyroid hormones influence serum leptin concentrations in the rat,” Endocrinology, vol. 138, no. 10, pp. 4485–4488, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. J. M. Diekman, J. A. Romijn, E. Endert, H. Sauerwein, and W. M. Wiersinga, “Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and hypothyroid women,” Thyroid, vol. 8, no. 12, pp. 1081–1086, 1998. View at Google Scholar · View at Scopus
  7. L. Vona-Davis and D. P. Rose, “Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression,” Endocrine-Related Cancer, vol. 14, no. 2, pp. 189–206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. D. Deo, A. P. Rao, S. S. Bose et al., “Differential effects of leptin on the invasive potential of androgen-dependent and -independent prostate carcinoma cells,” Journal of Biomedicine and Biotechnology, vol. 2008, no. 1, Article ID 163902, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. H. Pinkney, S. J. Goodrick, J. Katz et al., “Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects,” University of Bristol, Department of Medicine, Bristol Royal Infirmary, Bristol, UK.
  10. H. Y. Park, H. M. Kwon, H. J. Lim et al., “Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro,” Experimental and Molecular Medicine, vol. 33, no. 2, pp. 95–102, 2001. View at Google Scholar · View at Scopus
  11. Z. Liu, T. Uesaka, H. Watanabe, and N. Kato, “High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin,” International Journal of Oncology, vol. 19, no. 5, pp. 1009–1014, 2001. View at Google Scholar · View at Scopus
  12. R. Brauner, C. Trivin, M. Zerah et al., “Diencephalic syndrome due to hypothalamic tumour: a model of the relationship between weight and puberty onset,” Journal of Clinical Endocrinology and Metabolism, vol. 91, pp. 2467–2473, 2006. View at Google Scholar
  13. T. Jaffe and B. Schwartz, “Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways,” International Journal of Cancer, vol. 123, no. 11, pp. 2543–2556, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. N. O'Brien, B. H. Welter, and T. M. Price, “Presence of leptin in breast cell lines and breast tumors,” Biochemical and Biophysical Research Communications, vol. 259, no. 3, pp. 695–698, 1999. View at Publisher · View at Google Scholar
  15. L. Li, Y. Gao, L. L. Zhang, and D. L. He, “Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells,” Cancer Biology and Therapy, vol. 7, no. 11, pp. 1787–1792, 2008. View at Google Scholar · View at Scopus
  16. R. Ribeiro, A. Araújo, C. Lopes, and R. Medeiros, “Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator?” Journal of Thoracic Oncology, vol. 2, no. 2, pp. 105–108, 2007. View at Google Scholar · View at Scopus
  17. C. Garofalo and E. Surmacz, “Leptin and cancer,” Journal of Cellular Physiology, vol. 207, no. 1, pp. 12–22, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Hoda, S. J. Keely, L. S. Bertelsen, W. G. Junger, D. Dharmasena, and K. E. Barrett, “Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells,” British Journal of Surgery, vol. 94, no. 3, pp. 346–354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. O. O. Ogunwobi and I. L. P. Beales, “The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt,” International Journal of Colorectal Disease, vol. 22, no. 4, pp. 401–409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Uddin, R. Bu, M. Ahmed et al., “Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer,” Molecular Cancer, vol. 8, p. 74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. L. K. Lam, S. Wang, O. K. H. Ko, P. W. Kincade, and L. Lu, “Leptin signaling maintains B-cell homeostasis via induction of Bcl-2 and cyclin D1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 31, pp. 13812–13817, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Okumura, M. Yamamoto, H. Sakuma et al., “Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-α and PPAR expression,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1592, no. 2, pp. 107–116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. D. L. Morris and L. Rui, “Recent advances in understanding leptin signaling and leptin resistance,” American Journal of Physiology—Endocrinology and Metabolism, vol. 297, no. 6, pp. E1247–E1259, 2009. View at Publisher · View at Google Scholar
  24. Y. Wang, K. K. Kuropatwinski, D. W. White et al., “Leptin receptor action in hepatic cells,” Journal of Biological Chemistry, vol. 272, no. 26, pp. 16216–16223, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. R. R. Gonzalez, S. Cherfils, M. Escobar et al., “Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2),” Journal of Biological Chemistry, vol. 281, no. 36, pp. 26320–26328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Koda, M. Sulkowska, L. Kanczuga-Koda, E. Surmacz, and S. Sulkowski, “Overexpression of the obesity hormone leptin in human colorectal cancer,” Journal of Clinical Pathology, vol. 60, no. 8, pp. 902–906, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. J. Hong, K. W. Kwon, S. G. Kim et al., “Variation in expression of gastric leptin according to differentiation and growth pattern in gastric adenocarcinoma,” Cytokine, vol. 33, no. 2, pp. 66–71, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Koda, M. Sulkowska, A. Wincewicz et al., “Expression of leptin, leptin receptor, and hypoxia-inducible factor 1α in human endometrial cancer,” Annals of the New York Academy of Sciences, vol. 1095, pp. 90–98, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Ishikawa, J. Kitayama, and H. Nagawa, “Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer,” Clinical Cancer Research, vol. 10, no. 13, pp. 4325–4331, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Hu, S. C. Juneja, N. J. Maihle, and M. P. Cleary, “Leptin—A growth factor in normal and malignant breast cells and for normal mammary gland development,” Journal of the National Cancer Institute, vol. 94, no. 22, pp. 1704–1711, 2002. View at Google Scholar · View at Scopus
  31. N. K. Saxena, D. Sharma, X. Ding et al., “Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells,” Cancer Research, vol. 67, no. 6, pp. 2497–2507, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Uddin, P. Bavi, A. K. Siraj et al., “Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma,” Endocrine-Related Cancer, vol. 17, no. 1, pp. 191–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Valcavi, M. Zini, R. Peino, F. F. Casanueva, and C. Dieguez, “Influence of thyroid status on serum immunoreactive leptin levels,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1632–1634, 1997. View at Google Scholar · View at Scopus
  34. C. S. Mantzoros, H. N. Rosen, S. L. Greenspan, J. S. Flier, and A. C. Moses, “Short-term hyperthyroidism has no effect on leptin levels in man,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 2, pp. 497–499, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Légràdi, C. H. Emerson, R. S. Ahima, J. S. Flier, and R. M. Lechan, “Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus,” Endocrinology, vol. 138, no. 6, pp. 2569–2576, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Sreenan, J. F. Caro, and S. Refetoff, “Thyroid dysfunction is not associated with alterations in serum leptin levels,” Thyroid, vol. 7, no. 3, pp. 407–409, 1997. View at Google Scholar · View at Scopus
  37. R. Seven, “Thyroid status and leptin in Basedow-Graves and multinodular goiter patients,” Journal of Toxicology and Environmental Health—Part A, vol. 63, no. 8, pp. 575–581, 2001. View at Publisher · View at Google Scholar
  38. G. Mazziotti, A. B. Parkes, M. Lage, L. D. K. E. Premawardhana, F. F. Casanueva, and J. H. Lazarus, “High leptin levels in women developing postpartum thyroiditis,” Clinical Endocrinology, vol. 60, no. 2, pp. 208–213, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Akinci, F. Kosova, B. Cetin, S. Aslan, Z. Ari, and A. Cetin, “Leptin levels in thyroid cancer,” Asian Journal of Surgery, vol. 32, no. 4, pp. 216–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. S.-P. Cheng, C.-W. Chi, C.-Y. Tzen et al., “Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma,” Surgery, vol. 147, no. 6, pp. 847–853, 2010. View at Publisher · View at Google Scholar